Soloxine 0.3 mg Tablet
Soloxine 0.3 mg Tablet
Authorised
- Levothyroxine sodium
Product identification
Medicine name:
Soloxine 0.3 mg Tablet
Active substance:
- Levothyroxine sodium
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Levothyroxine sodium0.30/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QH03AA01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Ireland
Package description:
- High-density, brown, polyethylene bottles containing 250 tablets, hermetically sealed and closed with childproof screw cap
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone) - Council Directive 81/851/EEC
Marketing authorisation holder:
- Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
- Virbac
Responsible authority:
- Health Products Regulatory Authority
Authorisation number:
- VPA10988/069/003
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 3/05/2024
